MIAX Stock Forecast & Price Target

Miami International Hldgs is viewed positively because its core options franchise is still producing outsized monetization, with 2Q26 options net revenue of $124.4M beating expectations and RPC rising 6.0% Y/Y to 12.4¢, while adjusted EBITDA margin reached a record 54% on disciplined cost control. The company’s fundamentals are further strengthened by resilient market leadership and operating leverage: options ADV grew 25.3% Y/Y to 11.0M contracts, adjusted net revenue rose 35% Y/Y to $141.1M, and adjusted EBITDA increased 57% Y/Y to $76.8M, even as management continues to prioritize net revenue over share and sees pricing, mix, and fee changes supporting monetization. Additional upside comes from growth initiatives across futures, equities, and international markets, including healthier agricultural futures economics, improving equities capture, and a long-term Bloomberg futures opportunity, while lower adjusted opex guidance and a 10-year exclusive Bloomberg agreement add to the company’s scalable, capital-efficient growth profile.

Miami International Hldgs is viewed negatively because the company’s headline strength in options is being offset by a less reliable earnings mix, including a $22.5M Nasdaq litigation settlement charge in the options segment and $1.8M of episodic market-data revenue that management wants excluded from the 2H run rate, which makes the recent print look better than the underlying recurring base. While options net revenue grew 34% to $124.4M and adjusted EBITDA rose 44% to $96.7M with a 77.8% margin, the broader platform still shows dependence on one dominant segment, as futures net revenue was essentially flat at $5.1M with an adjusted EBITDA loss widening to $(9.5)M, and management itself signaled a more conservative 2H RPC range of roughly 10.3-11.0¢ versus the 12.4¢ seen in 2Q. In addition, the growth initiatives beyond options remain early and unproven—Bloomberg futures is still in onboarding mode and running at negative capture by design, fertilizer contracts do not launch until late October, and the retained minority stake in Rothera only preserves optionality—so the firm’s current valuation rests on a high operating-leverage story that still lacks clear evidence of durable diversification.